학술논문

RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS
Document Type
Article
Source
In: Leukemia. (Leukemia, July 2022, 36(7):1898-1906)
Subject
Language
English
ISSN
14765551
08876924